Latest news
Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test - TradingViewTradingView · Thu, 06 Aug 2026 13:30:00 GMTASX Quarterly Healthcare Wrap - Adelaide NowAdelaide Now · Wed, 29 Jul 2026 01:41:21 GMTLumos Diagnostics Reports 875% FebriDx Revenue Growth Driven by US Commercialisation and CLIA Waiver Milestone Payments - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMTLumos Diagnostics Reports 875% Surge in FebriDx Revenue Amid US Commercial Expansion and CLIA Waiver Milestone Payments - Kalkine MediaKalkine Media · Mon, 27 Jul 2026 07:00:00 GMT